Many studies have confirmed that CRP levels are higher in the stable stage of COPD than in normal individuals because, although specific inflammation is less severe than in the acute exacerbation stage, non-specific inflammation still persists. The gene discussed is CRP; the disease is chronic obstructive pulmonary disease.